The Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Invests in Expansion of Quality Control Program for Blood and CSF Biomarkers ...Middle East

New investment helps to ensure patients can access high-quality and reproducible testing across labs worldwide NEW YORK, June 2, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced an investment of up to $2M to expand a quality control program for blood...

Read More Details
Finally We wish PressBee provided you with enough information of ( The Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Invests in Expansion of Quality Control Program for Blood and CSF Biomarkers )

Also on site :

• Exactly How Many Times a Week To Walk To Improve Your Heart Health, According to Cardiologists
• DWTS Pros Support Beloved Mirrorball Winner, 38, Amid Personal News
• Israel orders military to block aid flotilla carrying Greta Thunberg from reaching Gaza